FDA Approves TOPIRAMATE — Cipla USA Inc.

# FDA Approves Generic Topiramate from Cipla USA Inc. Cipla USA Inc. received FDA approval for its generic topiramate oral formulation on March 27, 2009, potentially expanding treatment access for epilepsy and migraine prevention while intensifying competition in the anticonvulsant market. The approval is expected to lower costs for patients and payers as generic alternatives enter the marketplace against branded topiramate products.